Antibody avidity as a surrogate marker of successful priming by Haemophilus influenzae type b conjugate vaccines following infant immunization

Journal of Infectious Diseases

Volumn 177, Issue 4, 1998, Pages 1112-1115

  Goldblatt, D ^a   Pinto Vaz, A R J P M ^a   Miller, E ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN G ANTIBODY; ORAL POLIOMYELITIS VACCINE;

ANTIBODY AFFINITY; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOLOGICAL MEMORY; INFANT; INFLUENZA VACCINATION; INTRAMUSCULAR DRUG ADMINISTRATION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

EID: 17344361836     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/517407     Document Type: Article

References (17)

1. Adams WG, Deaver KA, Cochi SL, et al. Decline of childhood Haemophilus influenzas type b (Hib) disease in the Hib vaccine era. JAMA 1993; 269:221-6.
2. Käyhty H, Peltola H, Karanko V, Mäkelä P. The protective level of serum antibodies to capsular polysaccharide of Haemophilus influenzae type b. J Infect Dis 1983;147:1100-3.
3. Goldblatt D. Simple solid phase assays of avidity. In: Turner MW, Johnstone AP, eds. Immunochemistry 2: a practical approach. Oxford: IRL Press at Oxford University Press, 1997:31-51.
4. Goldblatt D, Fairley CK, Cartwright K, Miller E. Interchangeability of conjugated Haemophilus influenzae type b vaccines during the primary immunisation of infants at 2, 3, and 4 months. Br Med J 1996;312:817-8.
5. Begg NT, Miller E, Fairley CK, et al. Antibody responses and symptoms after DTP and either tetanus or diphtheria Haemophilus influenzae type b conjugate vaccines given for primary immunisation by separate or mixed syringe. Vaccine 1995;13:1547-50.
6. Phipps DC, West J, Eby R, Koster M, Madore DV, Quataert SA. An ELISA employing a Haemophilus influenzae type b oligosaccharide-human serum albumin conjugate correlates with the radioantigen binding assay. J Immunol Methods 1990;135:121-8.
7. Goldblatt D, van Etten L, van Milligen FJ, Aalberse RC, Turner MW. The role of pH in modified ELISA procedures used for the estimation of functional antibody affinity. J Immunol Methods 1993;166:281-5.
8. Schlesinger Y, Granoff DM. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. JAMA 1992;267:1489-94.
9. MacDonald RA, Hosking CS, Jones CL. The measurement of relative antibody affinity by ELISA using thiocyanate elution. J Immunol Methods 1988;106:191-4.
10. McCloskey N, Turner MW, Goldblatt D. Correlation between the avidity of mouse-human chimeric IgG subclass monoclonal antibodies measured by solid phase elution ELISA and biospecific interaction analysis (BIA). J Immunol Methods 1997;205:67-72.
11. Goldblatt D, Johnson M, Evans J. Antibody responses to Haemophilus influenzae type b conjugate vaccine in children with sickle cell disease. Arch Dis Child 1996;75:159-61.
12. Scheifele D, Law B, Mitchell L, Ochnio J. Study of booster doses of two Haemophilus influenzae type b conjugate vaccines including their interchangeability. Vaccine 1996;14:1399-406.
13. Kurikka S, Käyhty H, Saarinen L, Ronnberg PR, Eskola J, Mäkelä PH. Immunologic priming by one dose of Haemophilus influenzae type b conjugate vaccine in infancy. J Infect Dis 1995;172:1268-72.
14. Agbarakwe AE, Griffiths H, Begg N, Chapel HM. Avidity of specific IgG antibodies elicited by immunisation against Haemophilus influenzae type b. J Clin Pathol 1995;48:206-9.
15. Schlesinger Y, Granoff DM, Vaccine Study Group. Avidity and bactericidal activity of antibody elicited by different Haemophilus influenzae type b conjugate vaccines. JAMA 1992;267:1489-94.
16. Eskola J, Olander R, Hovi T, Litmanen L, Peltola S, Käyhty H. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine. Lancet 1996;348:1688-92.
17. Booy R, Heath PT, Slack MPE, Begg N, Moxon ER. Vaccine failures after primary immunisation with Haemophilus influenzae type-b conjugate vaccine without booster. Lancet 1997;349:1197-202.